Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.

Thus, our findings suggest that there is an increasing trend in current ESA use practice in more careful consideration when and in whom to start ESA (e.g. lower dosage, later introduction of ESAs in non-dialysis CKD population).

also in 63,971 other papers